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IGF1 activates cell cycle arrest following irradiation by
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Radiotherapy for head and neck tumors often results in persistent loss of function in salivary glands. Patients suffering
from impaired salivary function frequently terminate treatment prematurely because of reduced quality of life caused by
malnutrition and other debilitating side-effects. It has been previously shown in mice expressing a constitutively active form of
Akt (myr-Akt1), or in mice pretreated with IGF1, apoptosis is suppressed, which correlates with maintained salivary gland
function measured by stimulated salivary ﬂow. Induction of cell cycle arrest may be important for this protection by allowing
cells time for DNA repair. We have observed increased accumulation of cells in G2/M at acute time-points after irradiation in
parotid glands of mice receiving pretreatment with IGF1. As p21, a transcriptional target of the p53 family, is necessary for
maintaining G2/M arrest, we analyzed the roles of p53 and p63 in modulating IGF1-stimulated p21 expression. Pretreatment with
IGF1 reduces binding of DNp63 to the p21 promoter after irradiation, which coincides with increased p53 binding and sustained
p21 transcription. Our data indicate a role for DNp63 in modulating p53-dependent gene expression and inﬂuencing whether
a cell death or cell cycle arrest program is initiated.
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Over 50000 cases of head and neck cancer are expected to
be reported in the United States in 2010.
1 For these cancers,
radiation therapy is a common treatment modality, but
irradiation of this region often results in secondary side-
effects in non-diseased tissues, including drastic loss of
salivary gland function. This reduction in salivary ﬂow leads
to xerostomia, or chronic dry mouth, which can have a
profound effect on a patient’s quality of life. Those affected
have difﬁculty speaking, chewing and swallowing, and often
suffer from malnutrition.
2 To minimize these complications,
clinicians attempt to limit the dose of therapeutic radiation
reaching the parotid gland to 1.8–2Gy fractions totaling no
more than 26Gy over the course of treatment.
3 However, on
the basis of tumor location and lymph node involvement,
sparing of salivary glands may not be possible, with higher
radiation doses resulting in permanent loss of function.
On DNA damage, the molecular sensors ATM (ataxia
telangiectasia mutated) and ATR (ATM and Rad3-related)
phosphorylate p53 at Ser
15.
4–6 It has been suggested that
phosphorylation at this site is required for p53 stability in
response to ionizing radiation.
7 Stabilized p53 can then
transactivate genes involved in cell death, cell cycle arrest
and DNA repair.
8 The response of a particular cell type or
tissue to DNA damage likely depends on which of these
programs is initiated by p53. We have previously shown a
dose-dependentlossofsalivaryacinarcellstop53-dependent
apoptosis after irradiation of mice, which coincides with
a reduction in glandular function.
9 In addition, activation of
endogenous Akt by IGF1 suppresses DNA damage-induced
apoptosis in a parotid acinar cell line (C5) as well as in primary
cultures of enriched acinar cells.
Although p53-dependent apoptosis has been extensively
studied, identiﬁcation of p53 homologs (p63 and p73) has
added additional complexity to the understanding of how
apoptosisisregulated.Transcriptionfromalternatepromoters
results in two groups of p63 isoforms – full-length proteins
containing a transactivation domain (TAp63) and truncated
proteins lacking this domain (DNp63).
10 As a result of
alternative splicing, each of these groups consists of three
isoforms (a, b and g). In general, the TA isoforms function
similarly to p53, whereas the DN isoforms antagonize TAp63
as well as p53. Studies in several cell lines have shown
that DNp63a can bind to p53 response elements, leading
to reduced expression of genes such as MDM2, IGFBP-3
and p21.
11–13
Inthisstudy,weshowthatparotidglandsofmicepretreated
withintravenousIGF1beforeheadandneckirradiationexhibit
increased G2/M arrest compared with glands of mice treated
with radiation alone. This coincides with sustained expression
of p21 and elevated levels of cdc2 (Tyr
15) phosphorylation,
which are known G2/M checkpoint regulators.
14 We also
show that IGF1-induced cell cycle arrest is dependent on
Akt and p53. Owing to a potential role for DNp63 in regulating
p53targetgenes,weperformedchromatinimmunoprecipitation
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www.nature.com/cddis(ChIP) to evaluate p21 promoter occupancy at acute time-
points in the glands of irradiated mice. Parotid glands of mice
pretreated with IGF1 exhibit reduced binding of DNp63 to the
p21 promoter, whichcorresponds toincreased bindingof p53,
higher expression of p21 and G2/M arrest. Overall, our results
suggesta roleforDNp63indirectingp53toinitiateeitheracell
death or cell cycle arrest program. Insights into this mecha-
nism may provide an important translational opportunity for
development of small molecules to minimize side-effects of
cancer therapies.
Results
Increased cell cycle arrest in irradiated parotid glands
pretreated with IGF1. Radiation-induced DNA damage
activates p53, which transactivates genes involved in cell
death, cell cycle arrest and DNA repair.
8 We have previously
shown that IGF1 activates endogenous Akt in vivo and
suppresses radiation-induced apoptosis; this correlates with
preservation of salivary gland function.
15 Studies in vitro
have indicated that radiation can lead to accumulation of
cells in G2/M, thereby reducing the S-phase population.
14
To examine this, single cell suspensions from treated parotid
glands were stained with propidium iodide and analyzed
by ﬂow cytometry. Interestingly, radiation alone does not
alter the percentage of cells in G2/M 8h after treatment
(Figure 1a). In contrast, cells isolated from parotid glands
of mice pretreated with IGF1 have a fourfold increase in
the G2/M population compared with untreated mice and a
corresponding reduction in the percentage of S-phase cells
(Figure 1b). To conﬁrm that IGF1 induces arrest in irradiated
salivary glands, we measured proliferation by staining
tissue sections for proliferating cell nuclear antigen (PCNA).
The percentage of PCNA-positive acinar cells after 24h is
unchanged in the glands of mice treated with radiation alone,
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Figure 1 Pretreatment with IGF1 induces cycle arrest in irradiated parotid glands. The head and neck regions of wild-type mice were irradiated ±IGF1 pretreatment.
Parotid glands were removed 4, 8, 24 and 48h after treatment. (a, b) In all, 8h tissues were dispersed, stained with propidium iodide and analyzed by ﬂow cytometry.
The data are shown as the mean percentage of gated cells in G2/M (a) or S phase (b) þS.E.M. of X3 mice per treatment. (c) In total, 24 and 48h tissues were
embedded in parafﬁn and stained for PCNA. The graphs represent the number of PCNA-positive acinar cells as a percentage of total acinar cells counted. The data are
shown as the meanþS.E.M. of X3 mice per treatment. Representative PCNA images are shown below the graph. (d) RNA was isolated from 4, 8 and 24h tissues, and
real-time RT-PCR was run with primers to amplify total p63. Results were calculated using the 2
 DDCt method, normalized to untreated and shown as the meanþS.E.M.
of X3 mice per treatment. (e, f) Protein lysates were prepared from 8 (e) and 6h (f) tissues, and western blotting was performed as described in Materials and
methods. Total ERK was used to conﬁrm equal loading of lanes. *A signiﬁcant difference (Pp0.05) between irradiated glands±IGF1 pretreatment as measured by a
Student’s t-test
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Cell Death and Diseasebut decreases substantially in mice pretreated with IGF1
(Figure 1c). After 48h, the percentage of PCNA-positive
acinar cells in the glands of mice pretreated with IGF1 returns
to untreated levels.
DNA damage-induced G2/M arrest depends on expression
of p21, an inhibitor of the cyclin-dependent kinase cdc2.
14
To determine if IGF1-mediated G2/M arrest is facilitated by
p21, we used real-time RT-PCR to look for differences in
p21 expression in parotid glands of irradiated mice with
and without IGF1 pretreatment. There is signiﬁcantly higher
p21 expression after 8 and 24h in parotid glands of mice
pretreated with IGF1 than in those treated with radiation
alone (Figure 1d), which coincides with increased protein
(Figure 1e). IGF1 pretreated mice receiving radiation also
have elevated levels of phosphorylated cdc2 (Tyr
15) and
decreased levels of the phosphatase cdc25A (Figure 1f), all
of which indicate checkpoint activation. Collectively, these
data suggest that IGF1 stimulation before irradiation induces
an acute, transient G2/M arrest and may explain the reduced
apoptotic phenotype and preserved physiological function we
previously reported in IGF1 pretreated parotid glands.
15
Increased cell cycle arrest in irradiated parotid glands
of mice involves Akt. IGF1 is a potent activator of Akt
in salivary acinar cells in vitro and in vivo.
15,16 We have
previously described the phenotype of myr-Akt1 transgenic
mice;
17 similar to mice injected with IGF1, myr-Akt1 mice
have reduced radiation-induced apoptosis and preserved
salivary gland function.
15 To determine the effect of consti-
tutively active Akt (myr-Akt1) on radiation-induced G2/M
arrest, we irradiated transgenic mice expressing a consti-
tutively active form of Akt (myr-Akt1) and assessed cell cycle
distribution as described above. Contrary to wild-type mice
treated with radiation alone (Figure 1a), the parotid glands of
irradiated myr-Akt1 mice have a larger G2/M population than
untreated glands (Figure 2a). Similarly, these same glands
have decreased proliferation measured by PCNA staining,
24 and 48h after irradiation (Figure 2b). We also evaluated
the effect of myr-Akt1 on p21 expression after irradiation.
After 8 and 24h, p21 expression increases signiﬁcantly in
parotid glands of myr-Akt1 mice treated with radiation,
(Figure 2c). As cell cycle arrest in irradiated myr-Akt1
parotid glands is similar to the response in IGF1 pretreated
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Figure 2 Radiationinduces cellcyclearrestin myr-Akt1mice.The headandneckregionsof myr-Akt1 micewereirradiated(a–c). Parotidglandswere removed8, 24 and
48haftertreatment.(a)Inall,8htissuesweredispersed,stainedwithpropidiumiodideandanalyzedbyﬂowcytometry.Thedataareshownasthemeanpercentageofgated
cells in G2/MþS.E.M. of X3 mice per treatment. (b) In total, 24 and 48h tissues were embedded in parafﬁn and stained for PCNA. The graphs represent the number
of PCNA-positive acinar cells as a percentage of total acinar cells counted. The data are shown as the meanþS.E.M. (c) RNA was isolated from 8 and 24h tissues, and
real-timeRT-PCRwasrunwithprimerstoamplifyp21.Resultswerecalculatedusingthe2
 DDCtmethod,normalizedtowild-typeuntreatedandshownasthemeanþS.E.M.
of X3 mice per treatment. *A signiﬁcant difference (Pp0.05) between untreated and irradiated glands. (d) Wild-type mice were treated intraperitoneally with deguelin
(4mg/kg) immediately before IGF1 injections and head and neck irradiation. Parotid glands were removed after 8h, RNA was isolated, and real-time RT-PCR was run with
primers to amplify p21. Results were calculated using the 2
 DDCt method, normalized to vehicle control (DMSO alone) and shown as the meanþS.D.
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Cell Death and Diseaseparotid glands, we assessed whether the effects of IGF1
were mediated through Akt activation using the Akt inhibitor
deguelin. Pretreatment with deguelin reduces IGF1-induced
p21 expression in irradiated parotid glands by roughly 50%
(Figure 2d). These results imply that the IGF1-induced
cell cycle arrest in irradiated parotid glands may involve Akt.
Sustained phosphorylation of p53 (Ser
18) in parotid
glands of irradiated mice. In response to DNA damage,
p53 undergoes a number of posttranslational modiﬁcations
that increase its stability and transcriptional activity. It
has been suggested that phosphorylation at Ser
15 stabi-
lizes p53 after irradiation, allowing for transactivation of p53
target genes.
7 Phosphorylation of the corresponding site in
mice (Ser
18) also occurs in irradiated parotid glands.
17 We
evaluated DNA damage-induced changes to p53 protein
levels in parotid glands by probing for total and phosphory-
lated p53 (Ser
18). Although elevated over untreated, the level
of phosphorylated p53 protein (Ser
18) is signiﬁcantly reduced
in IGF1 pretreated glands after 8h compared with glands
treated with radiation alone (Figures 3a and b). These results
indicate that IGF1 reduces DNA damage-induced p53
phosphorylation and stabilization in parotid glands 8h after
irradiation.
Radiation-induced cycle arrest in parotid glands is
dependent on p53. To assess whether or not IGF1-
induced G2/M arrest is p53 dependent, we irradiated
p53
 /  mice with or without IGF1 pretreatment and stained
parotid tissue for PCNA. After 24h, the percentage of PCNA-
positive acinar cells was unchanged in the glands of p53
 / 
mice treated with radiation alone (Figure 4a). In contrast
to wild-type mice, the percentage of PCNA-positive acinar
cells increases signiﬁcantly in the glands of p53
 /  mice
pretreated with IGF1. Recent work from our lab showed that
radiation-induced expression of two canonical p53 target
genes, Bax and PUMA, is p53 dependent in parotid glands.
9
To conﬁrm this relationship for another canonical p53
target gene, the cell cycle arrest gene p21, we used real-time
RT-PCR to measure its transcription 4h after irradiation
in p53
þ/þ, p53
þ/  and p53
 /  mice. In both p53
þ/þ and
p53
þ/  parotid glands, p21 increases signiﬁcantly 4h after
irradiation compared with untreated glands from mice of
the same genotype (Figure 4b). In p53
 /  mice there is no
induction of p21 after irradiation, showing that radiation-
induced p21 transcription is p53 dependent.
To conﬁrm that IGF1 affects p21 expression in a p53-
dependent manner, we used real-time RT-PCR to measure
p21 expression in p53
 /  parotid glands 8h after irradiation.
Without functional p53, there is no increase in p21 trans-
cription 8h after irradiation (Figure 4c). We conﬁrmed
the requirement for p53 transcriptional activation in IGF1-
mediated p21 expression using piﬁthrin-a. Pretreatment with
piﬁthrin-a prevents the sustained p21 expression observed
in parotid glands of mice pretreated with IGF1 (Figure 4d).
These data show that IGF1-induced G2/M arrest in irradiated
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Figure 3 ParotidglandsofirradiatedmicepretreatedwithIGF1havereducedlevelsoftotalandphosphorylatedp53protein.Theheadandneckregionsofwild-typemice
were irradiated ±IGF1 pretreatment. Parotid glands were removed, protein lysates were prepared, and western blotting was performed (a) as described in Materials and
methods. Total ERK was used to conﬁrm equal loading of lanes. (b, c) Blots were analyzed by densitometry, normalized to total Erk and shown as mean intensity relative to
untreatedþS.E.M. *A signiﬁcant difference (Pp0.05) between irradiated glands ±IGF1 pretreatment as measured by a Student’s t-test
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Cell Death and Diseaseparotid glands, which occurs in wild-type animals, is p53
dependent.
Reduced levels of p63 in irradiated parotid glands
pretreated with IGF1. An exact role for p63 in modulating
DNA damage response is unknown; however, because of its
ability to enhance or inhibit p53 transcriptional activity,
10 we
chose to examine the effects of radiation on p63 expression
in parotid glands. We performed RT-PCR for TAa,T A g, DNa
or DNg to determine the isoforms expressed in salivary
glands. The only detectable isoforms were DNa and DNg
(Figure 5a), which are also the only isoforms detectable by
western blotting (Figure 5c).
Similarly to p53, p63 is affected by posttranslational
modiﬁcations. A recent study showed that p63 is phosphory-
lated (Ser
66/68 in DN) in response to genotoxic stress, which
may enhance its stability by reducing proteasomal degrada-
tion.
18 Levels of p63 in irradiated parotid glands were
evaluated by real-time RT-PCR and western blotting for total
and phosphorylated p63 (Ser
66/68). Radiation leads to a
signiﬁcant increase in p63 expression after 4h as measured
by real-time RT-PCR (Figure 5b). Increased transcription
coincides with elevated total p63 protein after 8 and 24h
(Figure 5c). In contrast, pretreatment with IGF1 prevents
increased p63 transcription after irradiation (Figure 5b). In
addition, parotid glands from irradiated mice pretreated with
IGF1 have reduced total p63 protein levels 8 and 24h after
treatment (Figure 5c). The same trend is observed when
probing for phosphorylated p63 (Figure 5c), although reduc-
tion of phosphorylated p63 in the parotid glands of IGF1
pretreated mice 24h after irradiation may simply be due to an
overallreductioninp63protein.Thesedataindicatethatacute
radiation-induced increases in total and phosphorylated p63
are not maintained in parotid glands of irradiated mice
pretreated with IGF1.
Reduced binding of DNp63 and increased binding of p53
to the p21 promoter in irradiated parotid glands
pretreated with IGF1. The DN isoforms of p63 have been
shown to function as transcriptional repressors in vitro,
reducing expression of p53 target genes, such as p21, by
binding to p53 response elements in their promoters.
11–13
Owing to increased p21 expression and G2/M arrest in
irradiated mice pretreated with IGF1, we sought to determine
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Figure 4 IGF1-inducedcell cycle arrest in irradiated parotid glands is p53 dependent. The head and neck regions of wild-type (p53
þ/þ), p53
þ/  and p53
 /  micewere
irradiated(a–c).After4,8and24h,parotidglandswereremoved.(a)Inall,24htissueswereembeddedinparafﬁnandstainedforPCNA.Thegraphsrepresentthenumberof
PCNA-positive acinar cells as a percentage of total acinar cells counted. The data are shown as the meanþS.E.M. of X3 mice per treatment. *A signiﬁcant difference
(Pp0.05)betweenp53
þ/þ andp53
 / glandsasmeasuredbyaStudent’st-test.(b,c)RNAwasisolatedafter4(b)and8h(c),andreal-timeRT-PCRwasrunwithprimers
to amplify p21. Results were calculated using the 2
 DDCt method, normalized to wild-type untreated and shown as the meanþS.E.M. of X3 mice per treatment.
*A signiﬁcant difference (Pp0.05) between untreated and irradiated glands of the same genotype (b) or irradiated glands ±IGF1 pretreatment (c). (d) Wild-type mice were
treatedinterperitoneally with piﬁthrin-a (0.25mg) for 12h, then again immediately before IGF1 injectionand head and neckirradiation.Parotid glands wereremoved after 8h,
RNAwasisolated,andreal-timeRT-PCRwasrunwithprimerstoamplifyp21.Resultswerecalculatedusingthe2
 DDCtmethod,normalizedtopiﬁthrin-aaloneandshownas
the meanþS.D.
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Cell Death and Diseasethe mechanism responsible using ChIP in vivo to evaluate
relative binding of p53 and DNp63 to a p53 response element
in the p21 promoter.
After 4h, radiation has no effect on the amount DNp63
bound to the p21 promoter in parotid glands, regardless of
whether or not mice were pretreated with IGF1 (Figure 6a).
This coincides with equivalent p21 expression in the two
groups of irradiated mice at that time-point (Figure 1d). After
8h, binding of DNp63 to the p21 promoter increases in
irradiated parotid glands, which is abrogated by pretreatment
with IGF1 (Figure 6a). Using a p63a-speciﬁc antibody, we
conﬁrmed that DNa is capable of binding to the p21 promoter;
however, p63g-speciﬁc antibodies speciﬁc for immunopreci-
pitation are commercially unavailable. This IGF1-mediated
reduction in binding of the transcriptional repressor DNp63 to
the p21 promoter may account for increased p21 expression
observed in this treatment group. A beads-only control using
no antibody for IP was no different from untreated controls
indicating that our pull-downs were speciﬁc (Figure 6b). The
fold enrichments shown represent trends that were consistent
betweenmultipleindependentexperiments.Theagarosegels
shown with each graph were loaded with PCR-ampliﬁed input
samples to show equal starting material for each IP.
We have shown that radiation-induced p21 expression is
p53 dependent in parotid glands (Figure 4b) and that
irradiated mice pretreated with IGF1 have sustained p21
expression (Figure1d). Owing to decreasedDNp63binding to
the p21 promoter in IGF1 pretreated glands (Figure 6a), we
hypothesized a concomitant increase in p53 binding to the
same response element. At both 4 and 8h after irradiation,
there is more p53 bound to the p21 promoter in the IGF1
pretreated group than in mice treated with radiation alone
(Figure 7a). Similar to Figure 6b, a beads-only control was no
different from untreated (Figure 7b). The fold enrichments
shownrepresenttrendsthatwereconsistentbetweenmultiple
independent experiments. These data indicate that IGF1 may
affecttheabilityofDNp63tofunctionasa competitiveinhibitor
to p53-induced transcription of p21 after irradiation.
IGF1-induced effects after irradiation are not detected in
unstressed salivary glands. We have shown that IGF1
given immediately before irradiation reduces inhibitory
binding of DNp63 to the p21 promoter, resulting in pro-
longed p21 gene expression and G2/M arrest. Generally,
growth factors are thought to drive proliferation rather than
induce cell cycle arrest. To test the hypothesis that IGF1
functions differently in irradiated glands than in unstressed
glands, we repeated several of the experiments reported
above in mice treated with IGF1 alone. Rather than
increasing the percentage of G2/M cells as it did
in irradiated glands, IGF1 increases the percentage of
S-phase cells indicating an actively dividing population
(Figure 8a). In parotid glands treated with IGF1, there is an
increase in total p53 (Figure 8b) but because IGF1 does not
initiate a DNA damage response, phosphorylation of p53
(Ser
15) is not observed (data not shown). IGF1 also induces
total p63 and phosphorylated DNp63a (Ser
66/68) 8 and 24h
after injection (Figure 8b). Owing to the critical role of p63 in
salivary gland development,
19,20 IGF1-induced proliferation
may account for this response. Consistent with a role for
IGF1 in driving proliferation in unstressed tissues, IGF1 alone
does not induce transcription of the cell cycle inhibitor p21
(Figure 8c). This corresponds with increased binding of the
transcriptional inhibitor DNp63 to the p21 promoter.
Altogether, these results indicate that parotid glands stres-
sed by radiation respond differently to IGF1 than unstressed
glands.
Discussion
Radiation-induced loss of salivary function in patients treated
for head and neck cancers is a severe morbidity that results in
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Figure 5 DNp63 mRNA and protein expression increases in irradiated parotid glands. (a) RNA was isolated from untreated parotid glands, and RT-PCR was run with
primers to amplify p63 isoforms (TAa, DNa,T A g and DNg). PCR products were electrophoresed on a 1% agarose gel. (b) The head and neck regions of wild-type mice were
irradiated ±IGF1 pretreatment. Parotid glands were removed, RNA was isolated and real-time RT-PCR was run with primers to amplify total p63. Results were calculated
usingthe2
 DDCt method,normalizedto untreated andshownas themeanþS.E.M.of X3 miceper treatment. *A signiﬁcantdifference(Pp0.05)betweenirradiatedglands
±IGF1pretreatmentasmeasuredbya Student’st-test.(c)Theheadandneckregionsofwild-typemicewereirradiated±IGF1pretreatment.Parotidglandswereremoved,
protein lysates were prepared and western blotting was performed as described in Materials and methods. Total ERK was used to conﬁrm equal loading of lanes
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Cell Death and Diseasechronic dry mouth, damaged oral mucosa, dysphagia and
malnutrition.
2 Currently, therapy is limited to palliative treat-
ment with muscarinic-cholinergic agonists, which stimulate
secretion from remaining salivary cells. In addition to the lack
of satisfactory functional results from these therapies, their
nonspeciﬁcactionproducesavarietyofside-effects,including
nausea, diarrhea and excessive sweating. As a result of this,
our research focuses on prevention of this damage.
In this study, we show that IGF1 elicits a different response
in parotid glands stressed by radiation than it does in glands
under normal conditions. Considerable evidence exists in the
literature on the functions of IGF1 in unstressed environ-
ments, with the majority of in vivo studies indicating a role in
cell and tissue hypertrophy (e.g., Stratikopoulos et al.
21).
Although studies in IGF1-null mice have indicated a role for
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Figure 6 Binding of DNp63 to the p21 promoter is reduced in parotid glands of
irradiated mice pretreated with IGF1. The head and neck regions of wild-type mice
were irradiated ±IGF1 pretreatment. (a) ChIP was performed on parotid glands
removed after 4 and 8h with an antibody recognizing total p63. (b) ChIP was
performedutilizing beads-onlyas a control.Precipitated DNA was analyzed by real-
timePCRusingprimersforaregionofthep21promoterB1390basesupstreamof
the transcription start site. Results were calculated by normalizing the Ct value for
each IP sample with the Ct value for its corresponding input (pre-IP chromatin) and
calculating a DCt. Normalized values are shown as fold versus untreated and
represent trends that were consistent between multiple independent experiments.
Agarose gels shown with each graph were loaded with PCR-ampliﬁed input
samples to show equal starting material for each IP
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Figure 7 Binding of p53 to the p21 promoter is increased in parotid glands of
irradiated mice pretreated with IGF1. The head and neck regions of wild-type mice
were irradiated ±IGF1 pretreatment. (a) ChIP was performed on parotid glands
removed after 4 and 8h with an antibody recognizing total p53. (b) ChIP was
performed utilizing beads-only as a control. Precipitated DNA was analyzed and
graphed as described for Figure 6. Normalized values are shown as fold versus
untreated and represent trends that were consistent between multiple independent
experiments
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Cell Death and DiseaseIGF1 in estradiol-induced G2 progression in the uterus,
22 few
studies have investigated the effects of exogenous IGF1 on
cell cycle progression in vivo. Our work uncovers a previously
unnoticed effect of IGF1 in environments stressed by
radiation. Speciﬁcally, we show that IGF1 induces a transient
cellcyclearrestinirradiatedglands,whichdoesnotoccurwith
radiation alone (Figure 1).
Our previous work has established that attrition of salivary
acinar cells to p53-dependent apoptosis is likely responsible
for the side-effects observed after head and neck irradia-
tion.
9,15,17 We hypothesize that cell cycle arrest in IGF1
pretreated mice facilitates DNA repair after irradiation,
thereby impeding apoptosis. One study showed that inhibition
of the DNA damage response by caffeine prevents G2/M
arrest and triggers apoptosis in irradiated MCF-7 cells.
23 In
osteosarcoma cells, inhibition of radiation-induced cell cycle
arrest is a potent radiation sensitizer.
24 This is a plausible
explanation for the sensitivity of salivary glands to radiation
because there are no indications of cell cycle arrest in mice
treated with radiation alone (Figure 1).
In salivary glands, IGF1 is a potent activator of the serine/
threonine protein kinase Akt (protein kinase B) pathway.
16 It
hasbeen shownthat constitutive activation of Akt1 (myr-Akt1)
in primary murine salivary acinar cells results in reduced
apoptosis after irradiation, which corresponds with decreased
p53 phosphorylation at Ser
18.
17 Most importantly, modulation
of the apoptotic response through activation of Akt (myr-Akt1
or a single intravenous dose of IGF1) correlates with
preserved salivary gland function after a single dose of
radiation.
15 Similar to IGF1 pretreated glands, transgenic
mice expressing myr-Akt1 have enhanced G2/M arrest,
reduced in proliferation and prolonged expression of p21
after irradiation (Figure 2). Pharmacological inhibition of Akt
reduces the ability of IGF1 to upregulate p21 expression in
response to radiation (Figure 2d), which suggests that IGF1-
mediated cell cycle arrest may involve Akt.
In contrast to what has previously been shown in the
literature, we indicate that IGF1 induces G2/M arrest after
irradiation, ostensibly through transcriptional upregulation of
p21 (Figure 1d). Mechanistically, we have shown that p21
promoter occupancy is different in parotid glands of IGF1
pretreated mice compared with parotid glands of mice treated
with radiation alone. Speciﬁcally, we illustrate that radiation-
induced increases in DNp63 protein correspond with
enhanced binding to the p21 promoter and decreased p21
transcription in irradiated parotid glands after 8h compared
with parotid glands pretreated with IGF1 (Figures 1d, 5b and
6a, respectively). Our study concurs with a previously
suggested role for DNp63 in mitigating DNA damage-induced
p21expression
12andhasextendedthisobservationtoinvivo.
Although slight differences in DNA binding sites make
promoters more selective for a speciﬁc p53 family member,
25
inhibition of p53 target genes by DNp63 may be due to
competitive binding to thesesites. Supporting this hypothesis,
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Figure 8 IGF1-induced effects after irradiation are not detected in unstressed salivary glands. Wild-type mice were treated with IGF1, and parotid glands were removed
after 4, 8, and 24h. (a) Cell cycle distribution was analyzed for 8h tissues as described for Figure 1a. The data are shown as the mean percentage of gated cells in
G2/M phaseþS.E.M. of X3 mice per treatment. (b) In all, 8 and 24h protein lysates were analyzed as described for Figure 3. (c) p21 mRNA expression was measured
after 8 and 24h as described for Figure 4. (d) ChIP was performed on 4 and 8h tissues with an antibody recognizing total p63 or total p53. Precipitated DNA was analyzed
and graphed as described for Figure 6. Normalized values are shown as fold versus untreated and represent trends that were consistent between multiple
independent experiments
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Cell Death and Diseaseweshow thatthereisaninverserelationshipbetweenp53and
DNp63 binding to the p21 promoter in the salivary glands of
mice pretreated with IGF1 before irradiation (Figure 7a).
Particularly, we show that in spite of the elevated levels of
p53 protein in irradiated glands (Figure 3), binding of p53 to
the p21 promoter decreases along with p21 transcription
(Figures 3 and 7a). Taken together, these data suggest that
in parotid glands of irradiated mice pretreated with IGF1,
reduced DNp63 protein facilitates a p53-mediated increase
in p21 expression leading to G2/M arrest.
It is well established that DNA damage results in stabilization
and increased transcriptional activity of p53;
7however, the genes
transcribed by p53 include both pro-apoptotic and cell cycle arrest
genes. Ourdata indicate that competitive binding of DNp63to p53
response elements in the p21 promoter may direct p53 to other
promoters, thereby accounting for selective activation of p53
target genes and initiation of a cell death or cell cycle arrest
program. In non-diseased salivary glands, suppression of
apoptosis by IGF1 results in a positive clinical output – the long-
term preservation of salivary function.
15 These results provide the
basis for rational design of small molecule inhibitors to prevent
radiation-induced attrition of salivary cells. The need for this is
urgent because there are currently no satisfactory methods to
protect or restore salivary gland function after radiation therapy.
Materials and Methods
Mice. All experiments were conducted in 4- to 5-week-old FVB females. For p53
knockout experiments, mice were provided by Dr. Carla van den Berg (University of
Texas, Austin, TX, USA) on a Balb/c background and back-crossed to FVB for
11 generations. For myr-Akt1 experiments, FVB mice expressing the myr-Akt1
transgene under control of the mouse mammary tumor virus promoter were
generatedat the University of Colorado Health Sciences Center. The salivary gland
phenotype was described previously.
17 Genotyping of transgenic mice was
conducted as previously described
17,26 using PCR primers from integrated DNA
technology (IDT, Coralville, IA, USA). All mice were maintained and treated in
accordancewithprotocolsapprovedbytheUniversityofArizonaInstitutionalAnimal
Care and Use Committee.
Treatment. Mice were treated with radiation, intravenous IGF1 or a combination
of the two. For irradiation, mice were anesthetized with avertin (0.4–0.6mg/kg) and
subjected to 5Gy of targeted head and neck irradiation (
60Co therapeutic irradiator,
Theratron-80, Atomic Energy of Canada Ltd, Ottawa, Canada) as previously
described.
9 Mice treated with IGF1 received 5mg of intravenous recombinant human
IGF1 (GroPrep, Adelaide, Australia) as previously described.
15 For those mice that
received the combination treatment, IGF1 injections occurred immediately before
irradiating the animal. For piﬁthrin-a experiments, mice were treated intraperitoneally
with 0.25mg (in 100ml of DMSO) of piﬁthrin-a (cyclic, hydrobromide, Enzo Life
Sciences, Plymouth Meeting, PA, USA) twice – 12h before, then immediately before
IGF1 injections and irradiation. For deguelin experiments, mice were treated
interperitoneallywith4mg/kg(ino100mlofDMSO)ofdeguelin(EnzoLifeSciences)
immediately before IGF1 injections and irradiation.
Flow cytometry. Pairs of glands were minced in dispersion media,
27 mixed at
371C for 20min, resuspended in modiﬁed Hank’s media with 1mM EGTA, and
mixed again at 371C for 10min. Tissue was disrupted by pipette and ﬁltered
through 20mm mesh. This single cell suspension was centrifuged (B100 g 
10min)2  incoldPBSandﬁxedbyadding500mlof100%ethanol.Afterstoringat
 201C overnight, cells were centrifuged (B100 g 15min), resuspended in
462.5ml of cold PBS and incubated at 371C for 30min with 25ml of RNase A
(10mg/ml, Invitrogen, Carlsbad, CA, USA) and 12.5ml of propidium iodide
(1.6mg/ml,MPBiomedicals,Solon,OH,USA).Cellcycledistributionwasmeasured
by the AZCC/ARL Division of Biotechnology Cytometry Core Facility using
a FACScan ﬂow cytometer (BD Biosciences, San Jose, CA, USA) and analyzed
using CellQuest Pro software (BD Biosciences).
PCNA staining. Glands were ﬁxed overnight in 10% neutral buffered formalin,
transferred to 70% ethanol and embedded in parafﬁn. Tissues were cut into 4mm
sections by the Histology Service Laboratory in the Department of Cell Biology and
Anatomy at the University of Arizona, Tucson, AZ, USA. Slides were stained for
PCNA (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Brieﬂy, slides were
heated to 371C for 30min and rehydrated in histoclear, graded alcohols and
distilled water. Nonspeciﬁc peroxidase activity was quenched with 0.3% H2O2. For
antigen retrieval, slides were placed in citrate buffer (pH 6.0), heated twice in
a microwave for 5min and allowed to cool. After washes, slides were treated
as instructed by the manufacturer (Vectastain Elite ABC kit, PK-6101, Vector
Laboratories, Burlingame, CA, USA). Color development was performed using
Biogenex (San Ramon, CA, USA) DAB incubation for 6–8min. Slides were
counterstained with Gill’s hematoxylin, dehydrated and mounted in Permount
(Thermo Fisher Scientiﬁc, Pittsburg, PA, USA). Images were made with a Leica
DM5500 (Leica Microsystems, Wetzlar, Germany) and 4 megapixel Pursuit camera
(DiagnosticInstruments, Inc, SterlingHeights,MI, USA).PCNA-positive acinarcells
in parotid sections were counted from a minimum of three ﬁelds of view per slide
from three slides per treatment (three mice).
Western blotting. Glands were homogenized in RIPA
17 supplemented with
SIGMAFAST protease inhibitor cocktail (Sigma-Aldrich, St Louis, MO, USA) and
5mMsodiumorthovanadate.Afteradding100mg/mlofPMSF,sampleswereboiled
for 10min and sonicated until homogenous. Protein concentrations were
determined using Coomassie Plus Protein Assay Reagent (Thermo Fisher
Scientiﬁc). In all, 100mg of each sample was loaded on an 8% polyacrylamide
gel, transferred to a 0.45mm Immobilon-P membrane (Millepore, Bedford, MA,
USA), and immunoblotted with one of the following antibodies: anti-ERK
(Promega, Madison, WI, USA), anti-p53 (DO-1, Santa Cruz Biotechnology), anti-
phosphorylated p53 (Ser
15) (Cell Signaling Technologies, CST, Beverly, MA, USA),
anti-p63 (4A4, Abcam, Cambridge, MA, USA), anti-phosphorylated p63 (Ser
66/68
in human DNp63) (CST), anti-phosphorylated cdc2 (Tyr
15) (Santa Cruz
Biotechnology), anti-cdc2 (Calbiochem/EMD, Gibbstown, NJ, USA), anti-cdc25a
(CST) and anti-p21 (Santa Cruz Biotechnology). Secondary antibodies were
conjugatedwith HRP(goat anti-mouseandgoat anti-rabbit,Bio-Rad,Hercules,CA,
USA; anti-mouse TrueBlot for anti-p63 and anti-phosphorylated p63 primaries,
eBioscience, San Diego, CA, USA; anti-goat for anti-phosphorylated cdc2, Santa
Cruz Biotechnology), and ECL substrate (Thermo Fisher Scientiﬁc) was used for
detection as instructed by the manufacturer. Membranes were stripped with restore
western blot stripping buffer (Thermo Fisher Scientiﬁc), reblocked and reprobed as
previously described.
17 Densitometry was analyzed using ImageJ (NIH, Bethesda,
MD, USA), normalized to total ERK and shown as mean intensity relative to
untreated.
RNA Isolation and RT-PCR. RNA was isolated as previously described
17
and quantiﬁed. In all, 1mg of RNA was reverse transcribed using a Super Script III
Kit as instructed by the manufacturer (Invitrogen) and diluted 1:5 for subsequent
analysis (PCR and gel electrophoresis or real-time PCR).
PCR and gel electrophoresis. Diluted cDNA was ampliﬁed using
AccuPower HotStart PCR PreMix with speciﬁc primers as instructed by the
manufacturer (Bioneer, Alameda, CA, USA). The following primers were purchased
from IDT: TAp63 forward: 50-ATGTCGCAGAGCACCCAG-30, DNp63 forward:
50-CCAGACTCAATTTAGTGAGCCAC-30, p63a reverse: 50-ACAACCTTGCTAAG
AAAACTGA-30, p63g reverse: 50-CTCCACAAGCTCATTCCTGAAGC-30. Products
were run on a 1% agarose gel.
Real-time PCR. The following real-time reaction mix was prepared: 5mlo f
diluted cDNA, 1ml of mixed forward and reverse primers (10mM each), 12.5mlo f
SYBR Green (Qiagen, Alameda, CA, USA), and nuclease-free water to a ﬁnal
volume of 25ml. Reactions were using an iQ5 Real-Time PCR Detection System
(Bio-Rad) and analyzed as previously described.
9 Normalized values were plotted
as relative fold over untreated. The following primers were purchased from IDT:
S15,
17 p21,
17 total p63 forward: 50-CGTCCAATTTTAATCATCGTTAC-30, total p63
reverse:50-CTGTCTTCATCTGCCTTCC-30.QuantiTectprimerformouseIGF1was
purchased from Qiagen.
Chromatin immunoprecipitation. Glands were ﬁxed in 1.5% paraformal-
dehyde for 10min, washed twice with cold PBS and resuspended in 750ml of RIPA
(50mMTris-HCl(pH8),150mMNaCl,2mMEDTA(pH8),1%NP-40,0.5%sodium
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Cell Death and Diseasedeoxycholate and 0.1% SDS) supplemented with SIGMAFAST protease inhibitor
cocktail (Sigma-Aldrich). After homogenizing, samples were sonicated eight times
for 15s at power¼2.0 using a Sonicator 3000 (Misonix, Farmingdale, NY, USA) to
yield B1kb DNA fragments. In all, 50ml of each chromatin sample was added to
70ml of elution buffer (1% SDS and 100mM sodium bicarbonate in PBS) with 10ml
of proteinase K (10mg/ml, Thermo Fisher Scientiﬁc) and incubated overnight at
651C. DNA was puriﬁed using a QIAquick PCR puriﬁcation kit (Qiagen) as
instructed by the manufacturer, eluted in 30ml, and quantiﬁed. DNA was diluted to
equal concentrations in DEPC water and set aside as the input fraction. Chromatin
samplesweredilutedinRIPAtoensureequalstartingmaterial(B15mgofDNA)for
subsequent IPs. Samples were cleared by incubating with 30ml of protein A/G
agarose beads (Thermo Fisher Scientiﬁc) for 1h at 41C. In another tube, 30mlo f
protein A/G agarose beads were incubated in RIPA with 2mg of sheared salmon
sperm DNA (Invitrogen), and 3ml of 1% BSA for 2h at room temperature. After
centrifugingandremovingthebeadsfromtheclearedIPsamples,thepre-absorbed
beads were added along with 3mg of antibody (total p63: mouse monoclonal (4A4),
Abcam; p63a: rabbit monoclonal (H-129), Santa Cruz; p53: rabbit polyclonal
(FL-393), Santa Cruz Biotechnology) and incubated overnight at 41C. Beads were
washed three times with wash buffer (150mM NaCl, 20mM Tris-HCl (ph 8), 2mM
EDTA, 1% Triton X-100 and 0.1% SDS), once with ﬁnal wash buffer (wash buffer
with 500mM NaCl), and resuspended in 120ml of elution buffer. After 15min, 10ml
of proteinase K (10mg/ml) was added, and samples were incubated overnight at
651C. IP DNA was puriﬁed in the same way as input DNA. For quantiﬁcation, equal
volumes of DNA from each IP and input sample were ampliﬁed by real-time PCR
(following the protocol described above) using primers for a region of the p21
promoterthatisB1390 basesupstreamof thetranscriptionstartsite (IDT,forward:
50-TCTTGCTATGTAGCCCATGT-30,r e v e r s e :5 0-TACGGATGTTCCTGACAGAC-30).
Results were calculated by normalizing the Ct value for each IP sample with the
Ct value for its corresponding input (pre-IP chromatin) and calculating a DCt.
Normalized values were graphed as fold over untreated. To conﬁrm equal starting
materialforeachIP,inputDNAwasampliﬁedusingthep21promoterprimersandrun
on a 1% agarose gel (see PCR and gel electrophoresis protocol above).
Statistical analysis. Single comparisons were made between two groups
using Student’s t-tests calculated with Microsoft Excel.
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